Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis
Marja Niiranen, Aleksi Kontkanen, Olli Jääskeläinen, Hanna-Mari Tertsunen, Tuomas Selander, Päivi Hartikainen, Nadine Huber, Eino Solje, Annakaisa Haapasalo, Tarja Kokkola, Tarja Lohioja, Sanna‐Kaisa Herukka, Sakari Simula, Anne M. Remes
Topics & Concepts
MedicineMultiple sclerosisGlial fibrillary acidic proteinGastroenterologyNatalizumabInternal medicineRelapsing remittingClinically isolated syndromeMcDonald criteriaBiomarkerImmunologyImmunohistochemistryChemistryBiochemistryMultiple Sclerosis Research StudiesNeurogenesis and neuroplasticity mechanismsAmyotrophic Lateral Sclerosis Research